Summary:
Study Evaluating the Safety and Efficacy of a new medication for the Treatment of Plaque Psoriasis.
Duration of the study is 56 weeks, including up to 16 clinic visits.
Criteria:18 years of age or older
Have a diagnosis of Plaque Psoriasis for at least 6 months
Have used a topical treatment that did not adequately controlled the disease
Qualified Participants May Receive:
Study medication, medical examinations, electrocardiograms, x-rays and laboratories at not cost.
Study patients will receive a compensation of $90.00 per completed visit for up to $1,440.00 for the completion of the study.